Sinommune™: Coronavirus Antigen Array
Featured Product ADVERTISEMENT May 01, 2020
Sino Biological and Nanommune Inc. debute the first product CoVAM coronavirus array under Sino Biological’s new brand SinommuneTM， which is a multiplex assay platform for high-throughput serological studies
These arrays are designed to determine the antibody profile in serum samples, and monitor its changes over time under different circumstances. The arrays are uniquely suitable for epidemiology studies, as they can be used as a serologic surveillance tool to determine the prevalence of the infection during an epidemic. Figure 1 showed the result from a recent jointed study published on Biorxiv. The heat map clearly showed a distinct IgG reactivity towards SARS-CoV-2 in eight convalescent specimens from recovered COVID-19 patients.
Serological Study of COVID-19
The most important application of these reagents is in serological diagnostics, both in forms of antigen detection and antibody detection. These reagents have already been used to manufacture FDA-approved diagnostic kits in the US. Several monoclonal antibodies developed by Sino Biological have been used in clinical testing of antigen detection, and received promising early results.
ProVirTM : Viral Antigen Bank
In March, the Sino Biological officially announced the launch of the world’s largest viral antigen bank, ProVirTM. This exclusive collection features over 800 antigens from 350 virus strains, including Zika, Ebola, Dengue, RSV, HIV, and HPV etc. It’s noteworthy that the ProVirTM collection also carries 600+ HA, NA, and ME antigens from 250 strains of influenza viruses, including vaccine strains and the pandemic strains such as the 2009 swine flu (A/California/04/2009 (H1N1)). Development of other 150 antigens is currently underway.
Find out more reagents for Serological Assay of SARS-CoV-2!
Contact us via firstname.lastname@example.org or visit www.sinobiological.com
EUROPE: +49(0)6196 9678656